Folate Receptor-α (FOLR1) Expression and Function in Triple Negative Tumors-Reference-Cited by-同舟云学术

Folate Receptor-α (FOLR1) Expression and Function in Triple Negative Tumors

Published:2015-03-27 Issue:3 Volume:10 Page:e0122209
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Necela Brian M.,Crozier Jennifer A.,Andorfer Cathy A.,Lewis-Tuffin Laura,Kachergus Jennifer M.,Geiger Xochiquetzal J.,Kalari Krishna R.,Serie Daniel J.,Sun Zhifu,Aspita Alvaro Moreno,O’Shannessy Daniel J.,Maltzman Julia D.,McCullough Ann E.,Pockaj Barbara A.,Cunliffe Heather E.,Ballman Karla V.,Thompson E. Aubrey,Perez Edith A.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference37 articles.

1. Breast cancer statistics, 2013;C DeSantis;CA Cancer J Clin,2014

2. Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011;A Goldhirsch;Ann Oncol,2011

3. Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer;EH Romond;N Engl J Med,2005

4. Adjuvant trastuzumab for HER2-positive early breast cancer;FM Palmieri;Clin J Oncol Nurs,2010

5. Treatment of HER2-positive breast cancer: current status and future perspectives;CL Arteaga;Nat Rev Clin Oncol,2012

Cited by 118 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Amorphous silica nanoparticles exhibit antitumor activity in triple‐negative breast cancer cells;Archiv der Pharmazie;2024-09-10

2. Synergistic anticancer activity of Sulphoraphane and Teriflunomide co loaded lignin nanoparticles against triple negative breast cancer: Targeted nanoparticle delivery and drug repurposing;Medical Hypotheses;2024-08

3. Theranostics Using MCM-41-Based Mesoporous Silica Nanoparticles: Integrating Magnetic Resonance Imaging and Novel Chemotherapy for Breast Cancer Treatment;International Journal of Molecular Sciences;2024-07-25

4. Folate Receptor Alpha Expression and the Tumor Immune Microenvironment in Patients with Cervical Cancer;International Journal of Gynecological Pathology;2024-06-12

5. Folic acid modified precision nanocarriers: charting new frontiers in breast cancer management beyond conventional therapies;Journal of Drug Targeting;2024-05-22